World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00851149
Date of registration: 23/02/2009
Primary sponsor: Sykehuset i Vestfold HF
Public title: Pro-inflammatory Cytokines in Blood From Orthopedic Surgery Compared to Abdominal Aneurysm Repair KEEP-HB
Scientific title: Pro-inflammatory Cytokines (IL-1beta,IL-6, IL-8 and TNF-a) and Complement Activation (C3a) in Blood Collected From Surgery Field From Patients Undergoing Orthopedic Surgery Compared to Patients Undergoing Abdominal Aneurysm Repair.
Date of first enrolment: November 2009
Target sample size: 20
Recruitment status: Active, not recruiting
URL:  http://clinicaltrials.gov/show/NCT00851149
Study type:  Observational
Study design:  Observational Model: Case Control, Time Perspective: Prospective  
Countries of recruitment
Norway
Contacts
Name:   Espen Lindholm, Md
Address: 
Telephone:
Email:
Affiliation:  Sykehuset i Vestfold HF
Key inclusion & exclusion criteria

Inclusion Criteria:

- ASA 1-4

Exclusion Criteria:

- Patient using corticosteroids, NSAIDs or Cox-II inhibitors

- Patients under 18 years

- Patients who are included in pharmaceutical studies

- Opioids-, benzodiazepines-, antiepileptic drugs-, alcohol- and a2-agonists abuse

- Pregnant and breastfeeding women

- Patients with known hypersensitivity for opioids, propofol or volatile anesthetics

- Patients with serious arrhythmias (atrial fibrillation/flutter is acceptable)

- Uncontrolled hypertension, serious psychiatric disease

- Patients with unstable angina pectoris or myocardial infarction the last month before
inclusion

- Acute abdominal aortic surgery (acute dissection or rupture)

- Planned laparoscopic abdominal aortic aneurysm surgery

- Transfusion of blood products last month before surgery

- Glucocorticoid users



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Aortic Diseases
Osteoarthritis, Hip
Intervention(s)
Device: Sangvia blood sampling system
Primary Outcome(s)
Pro-inflammatory cytokines (IL-6, IL-8 and TNF-a) and complement activation (C3a) in blood samples collected from surgery field. Comparison between the 2 groups. [Time Frame: 30 days]
Secondary Outcome(s)
Haemoglobin, Trc, INR in blood samples and plasma will be analysed and compared between the 2 groups. [Time Frame: 30 days]
Secondary ID(s)
6.2009.36
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Dentsply Implants
Oslo University Hospital
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history